Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003407051 | SCV004142071 | benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | BICRA: BS1, BS2 |
Ambry Genetics | RCV004364565 | SCV004914267 | uncertain significance | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | The c.2351C>T (p.P784L) alteration is located in exon 8 (coding exon 6) of the GLTSCR1 gene. This alteration results from a C to T substitution at nucleotide position 2351, causing the proline (P) at amino acid position 784 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV003407051 | SCV005209736 | likely benign | not provided | criteria provided, single submitter | not provided |